Polymethylmethacrylate bone cement is used for shaft fixation of artificial hip and knee joints. The reliable method has the advantage of a nearly immediate loading capacity after the implantation. In cases of hazards due to postoperative biomaterial associated infections [1] anti-inflammatory therapies are difficult [2] [3] [4] , lifelong and often to press an explantation of the implant. A prophylactic measure is the use of antibiotic loaded cement [5, 6] with the goal to reach sufficiently high level of antibiotics in the immediate vicinity of the implant, without stressing the organism excessively and the hope to avoid resistance. Oral intakes of antibiotics are mostly ineffectively because of reduced diffusion in the bone sphere. Commercially available are gentamicin loaded bone cements with an antibiotic content of about 2.5 %. In cases, if special antibiotics are required, the active incredients, one or two [7] are added to the cement powder by the physician during the operation. A fraction up to 10 % is in use. There is no knowledge about the influence of constituents of antibiotics to the cement powder with respect to the mechanical stability. But some recommendations are announced which say that a maximum of 10 % of incredients should not be exceeded [8] . The other constraint is the minimal amount of antibiotics to be effective against bacteria. Generally 90 % of the incorporated constituents are retained in the PMMA matrix [9, 10] , so that only small amounts are available in particular if a long term therapy is aspired. Hence the increase of bacterial resistance, mainly against bacteria responsible for infections on orthopaedic implants, leads to an increasing interest and search for new effective antimicrobial agents which have to be admixed to the cement by the clinician because commercial not available. There are some methods published applied for the determination of the antibiotic release rate. Although not validated results are available, it is generally accepted that the release rate during the first hours shows high values whereas the values strongly decrease in the long term application and finally are stabilized on a very low level over a few weeks [11] [12] [13] . The release kinetic is controlled by a combination of surface roughness and porosity [14] . A high roughness enlarges the surface and the amount of interfacial bonded agent molecules. Porous materials, permeable by the body electrolyte [15, 16] deliver effective molecules out of the region close to the surface. Porosity itself depends on the addition of antibiotics which leave pores after release [17] . 
Introduction
Polymethylmethacrylate bone cement is used for shaft fixation of artificial hip and knee joints. The reliable method has the advantage of a nearly immediate loading capacity after the implantation. In cases of hazards due to postoperative biomaterial associated infections [1] anti-inflammatory therapies are difficult [2] [3] [4] , lifelong and often to press an explantation of the implant. A prophylactic measure is the use of antibiotic loaded cement [5, 6] with the goal to reach sufficiently high level of antibiotics in the immediate vicinity of the implant, without stressing the organism excessively and the hope to avoid resistance. Oral intakes of antibiotics are mostly ineffectively because of reduced diffusion in the bone sphere. Commercially available are gentamicin loaded bone cements with an antibiotic content of about 2.5 %. In cases, if special antibiotics are required, the active incredients, one or two [7] are added to the cement powder by the physician during the operation. A fraction up to 10 % is in use. There is no knowledge about the influence of constituents of antibiotics to the cement powder with respect to the mechanical stability. But some recommendations are announced which say that a maximum of 10 % of incredients should not be exceeded [8] . The other constraint is the minimal amount of antibiotics to be effective against bacteria. Generally 90 % of the incorporated constituents are retained in the PMMA matrix [9, 10] , so that only small amounts are available in particular if a long term therapy is aspired. Hence the increase of bacterial resistance, mainly against bacteria responsible for infections on orthopaedic implants, leads to an increasing interest and search for new effective antimicrobial agents which have to be admixed to the cement by the clinician because commercial not available. There are some methods published applied for the determination of the antibiotic release rate. Although not validated results are available, it is generally accepted that the release rate during the first hours shows high values whereas the values strongly decrease in the long term application and finally are stabilized on a very low level over a few weeks [11] [12] [13] . The release kinetic is controlled by a combination of surface roughness and porosity [14] . A high roughness enlarges the surface and the amount of interfacial bonded agent molecules. Porous materials, permeable by the body electrolyte [15, 16] deliver effective molecules out of the region close to the surface. Porosity itself depends on the addition of antibiotics which leave pores after release [17] . A model for the antibiotic release consists of two parts, first the desorption of active molecules from the surface with the highest release rate; secondly the elution and diffusion from surface near regions and from inner regions via channels and cracks [18] . For diffusion of course the particle size of agents influences the diffusion. The complex dependency of release needs a standardized and validated method to clarify some open questions concerning the diffusion and release kinetic of antibiotics from acrylic bone cement. The experiments will show a dependency of the release from the flow rate as well as from the kind of antibiotics, associated with a different particle size.
Der

Materials and Methods
The experimental setup is manufactured from glas and steel according to AISI 316 L to avoid interactions and changes of the antibiotics, fig. 1 , and to assure sterilization of the particular components of the flow chamber. A reservoir for the eluting physiological solution is placed on the top; the fluid is driven through the chamber by gravitation. The pressure is kept in equilibrium due to a capillary tube with a resulting laminar flow. The flow rate is adjustable with a fine dosing valve at the bottom, comparable with an infusion back. As minimum flow rate a rate of 5 ± 0.5 ml/h is adjustable. An air trap between the reservoir and the sample chamber prevents the contamination of the reservoir with antibiotics. The samples can be changed without disturbing the system. The eluate drops into test-tubes on a time controlled fraction collector. The dimensions of the sample are 20 mm in height and 9 mm in diameter. The fluid volume between the outgoing valve and the sample chamber, "blind volume", is about 6 ml. It results a reasonable fluid volume to sample surface relation with regard to the expected concentrations. The eluate was collected up to 8 h. At a flow rate of more than 5 ml/h, the concentration was on a small level after a few hours decreasing not significantly. From this time on the commonly used insertion test with an outsourcing time of 24 h makes more sense. The concentration of the antibiotics in the eluate was determined by UV spectroscopy [19, 20] . For each antibiotic a calibration curve was recorded in steps of 5 mg/l, 10 mg/l, 20 mg/l, 40 mg/l, and 80 mg/l. The concentration dependant UVsignals are linear typically up to 80 mg/l, for ampicillin up to 50 mg/l. For higher concentrations the eluate has to be diluted. In the case of gentamicin a volume of 1.3 ml of the eluate has to be mixed for 30 sec at a vibrator with the same amount of isopropanol and a derivation solution described beneath [21] in order to achieve an improved sensitivity. After a holding time of 45 minutes the prepared solution is evaluated uv-vis spectroscopically. The solution is stable for one and a half hour, and the derivation mixture has to be renewed weekly. The derivation solution is mixed from 100 mg o-Phthaldialdehyd, 1.0 ml Methanol and 0.2 ml b-Mercaptoethanol and finally filled up to 100 ml 2% di-natriumtetraborat solution For the investigation of the temperature dependancy of antibiotic release Merck refobacin palacos bone cement with about 2.5 % gentamicin was used. For all other experiments wt. 5 % of antibiotics were added ad hoc on the basis of a Palacos bone cement powder. The preparation method was divided in two steps: In a first step identical amounts of bone cement powder and antibiotics are mixed; the second step double the weight by adding and mixing the same amount of pure bone cement powder to the first composition. The second step is repeated as long as the ratio of antibiotic is wt. 5 %. Afterwards the monomer was added in a cup and mixed with the powder. The samples are generated by filling a cylindrically teflon mold. After one hour the samples were removed from the mold. 
Results
The valve for adjusting the flow rate allows the variation in a distinct range. The flow was constant in a band of 10 %. Fluctuations in the flow rate arose mainly within the first 30 minutes because of the short time intervals and the low volume collected, fig. 2 . The constant flow rate is essential in order to compare differently prepared or differently mixed specimen. Most measurements were performed with a flow rate of 12 ml/h. That means within equidistant a time intervals of 5 minutes, 1 ml eluate is generated. Lower amounts lead to larger variations in the uv-vis measurement results. The flow rate of 12 ml/h combines a good time resolution and reasonable small error bars for the measurements of the released antibiotics. Fig. 3 shows the time dependent release for different antibiotics. The releaset was similar for gentamicin and vancomycin. The total amount of ofloxacin seemed to be much lower, the total amount of ampicillin was slightly higher. The data were averaged from three independent measurements. Errors occured mainly due to differences of the samples, which lead to the requirement of an optimized sample geometry.
The differences in the released amount arise potentially from different adhesion and bonding properties of the antibiotics in the cement. Both could be influenced by the medium particle size and molecular weight. The relative molecular weight is 371 atomic units (au) for ampicillin, 361 au for ofloxacin, 723 au for gentamicin sulphate and 1485 au for vancomycin hydrochloride. The largest particle size of the agent powder showed gentamicin; falling sizes can be seen by vancomycin and ofloxacin, the smallest by ampicillin. The influence of the flow rate on the measured release curve is shown in Fig. 4 . Specimens with w.t. 5 % gentamicin sulphate were rinsed in the flow chamber. The increasing part of the release curve resulted due to the design of the flow chamber. The specimen chamber contained 5 ml solution; the escape pipe catches another 1 ml solution. In the first 5 minutes agent free solution was collected. The diffusion of the released gentamicin seemed to be too slow. In the next interval of 5 minutes the diffusion as well as the flow was responsible for the increasing concentration. With decreasing flow the maximum concentration was shifted in time. The total amount of released gentamicin was not reflected by the variation of the flow, as shown in fig. 4 (above) . Fig. 5 shows the temperature dependency of the release for gentamicin with higher amounts of gentamicin in the eluate for increasing temperature.
The comparison of the release data determined at a constant flow rate with data measured by an immersion method shows fig. 6 . The immersion is performed in 20 ml physiological media for 24 h and leads to an average value over the time. The amounts of released gentamicin are normalized to the surface area of the specimen. Only the constant flow measurements permit the monitoring of the exponential time release decay within the first few hours.
Discussion
The release measurements under constant, laminar flow of the eluating medium of antibiotics from PMMA cement and an adjustable constant temperature lead to reproducible time resolved results during the first hours after the beginning of the experiment. The reproducibility depends mainly on the iden-
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Wolfgang Braun: Standardized release measurements for antibiotics from polymethylmethacrylate bone cement under constant flow tity of the sample geometry. Differences in the release kinetics of different antibiotics like gentamicin, vancomicin, ofloxacin, and summarized in fig. 3 . Ampicillin with the lowest molecular weight and concurrently with the smallest particle size presents the highest drug release. The small particle size favours the smooth dispersion of ampicillin within the cement powder and concurrently, the small molecules improve the diffusion from the inside to the outside. The molecular weight of vancomycin is nearly twice of the molecular weight of gentamicin. The vancomycin molecule is larger but the particle size of the powder is smaller than for gentamicin. The released amounts of both agents are similar. Up to now not explainable is the release rate of ofloxacin, because the particle size as well as the molecule size is small. The temperature dependent curves show equal or slightly lower release for higher temperatures in the first minutes whereby afterwards the release is higher with increasing temperature. It is possible that the surface desorption of the antibiotics is not affected in the same way as the diffusion of the agent in the solid surface region. The variation of the flow rate and the temperature offer two parameters which have to be included in a diffusion model. The comparison of the cummulative evaluated results with the commonly used "age-hardening" method over a constant time, f. I. 24 h, fig. 6 , shows good agreement, if normalized to the surface area for different sample geometries.
Conclusion
The presented method, measuring the release rate of different antibiotic from PM-MA bone cement under constant flow is able to measure time resolved the released agent amounts in dependence of molecular weight, particle size, and temperature and, if available, for different types of bone cements. The method is simple to apply, easy to handle and leads to first results within a few hours. The method is suitable to assess the properties of different antibiotic loaded bone cements. Also antibiotic loaded calcium phosphate cements can be characterized. The possibility to vary the flow rate and the temperature may be helpful to investigate the kinetics of drug release. The temperature dependence of release within the first hour and the time afterwards permits the assumption that two kinetics are behind the release mechanism.
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Abstract
A test method was established to determine the dynamic release of antibiotics from acrylic bone cement in vitro with high time resolution starting with the beginning of release. The release is measurable in dependence of the flow rate of an eluating fluid. The detection of the antibiotic or antibiotics in the eluate is performed via UV-absorption, showing characteristics for each of the antibiotics, that are gentamicin, ofloxacin, vancomycin, and ampicillin. Compared are the releases at the flow rate of 12 ml/h time released and cumulative along 6 h. A temperature dependent release of gentamicin from refobacin bone cement gives hints to the release kinetic. The validation of the method was performed by a second, often used measurement procedure. 
